Novo Nordisk's Wegovy Gets UK Nod for Higher 7.2 mg Weekly Dose in Obesity Treatment sheeba farhat17 Jan 2026 4:06 PM ISTThe authorisation for the drug, chemically known as semaglutide, covers only patients with a body mass index of 30 or higher using the drug for weight...
No Link to Suicidal Thoughts: USFDA Seeks Label Change for Popular Weight-Loss Drugs Wegovy, Zepbound sheeba farhat14 Jan 2026 6:57 PM ISTThe warnings, part of their original approval, were based on reports of such events observed with a variety of older medicines used or studied for...
Medical Bulletin 10/January/2026 Anshika Mishra10 Jan 2026 3:00 PM ISTHere are the top medical news for today:Review suggests most GLP-1 users regain weight within two years after stopping Weight loss drugs work wonders...
Review suggests most GLP-1 users regain weight within two years after stopping Anshika Mishra10 Jan 2026 8:00 AM ISTWeight loss drugs work wonders for shedding pounds, but stopping them can bring the weight back faster than ever. A new University of Oxford review...
Natco Pharma Challenges Novo Nordisk's Wegovy Patent, Reaches Delhi High Court Susmita Roy7 Jan 2026 11:19 PM ISTNew Delhi: Hyderabad-based Natco Pharma has approached the Delhi High Court with a petition seeking revocation of a patent held by Novo Nordisk, the...
Eli Lilly, Nimbus Tie Up in USD 1.35 Billion AI-Driven Pact to Develop Oral Obesity Drugs sheeba farhat7 Jan 2026 4:11 PM ISTNimbus will use its AI to help identify drug candidates, while Lilly will contribute its metabolic-disease expertise to develop an easy-to-take oral...
Novo Nordisk's US Public Affairs Head Jennifer Duck Exits Amid Pricing Pressure, Obesity Drug Battle sheeba farhat7 Jan 2026 4:04 PM ISTCEO Doustdar is trying to restore investor confidence by sharpening Novo's focus, after a tough year in which the company issued multiple profit...
Novo Nordisk Bets on Oral Wegovy to Take on Eli Lilly in US Obesity Market sheeba farhat5 Jan 2026 6:19 PM ISTThe Wegovy pill could attract new consumers as Novo looks to revive its fortunes after profit warnings and sliding shares in 2025.
Price war in China weight loss market: Novo Nordisk, Eli Lilly slash prices of Wegovy, Mounjaro Ruchika Sharma30 Dec 2025 6:08 PM ISTGlobal drugmakers Novo Nordisk and Eli Lilly have kicked off a price battle in China’s obesity treatment market, cutting prices of their blockbuster...
Eli Lilly, Novo Nordisk race to lock in India obesity drug market Ruchika Sharma26 Dec 2025 4:23 PM ISTHyderabad: Global pharma heavyweights Eli Lilly and Novo Nordisk are racing to lock in market leadership in India’s blooming obesity drug market,...
Pill form of Wegovy gets USFDA approval for weight loss Ruchika Sharma23 Dec 2025 1:30 PM IST Plainsboro: In a major development, Novo Nordisk has received approval from the US Food and Drug Administration (FDA) for popular GLP-1...
Novo Nordisk Gets CDSCO Panel Nod to Update Wegovy Label With New Safety, Pharmacodynamics Data Susmita Roy14 Dec 2025 12:43 AM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting approval to Novo...
